Squamous cell carcinoma research
With 13,000 new patients per year, squamous cell carcinoma is the second most common skin cancer and numbers continue to rise by more than 5% per year. A small proportion of squamous cell carcinoma patients develop metastases, but because it is unclear exactly who does this, all patients are currently receiving an intensive follow-up schedule to diagnose metastases as early as possible.
Through research in a unique national cohort of patients with and without metastases, she wants to learn to identify high-risk tumors early on the basis of patient characteristics, microscopic tumor characteristics and artificial intelligence. Artificial intelligence offers the possibility of training a computer by predicting who will develop metastases and who will not, by offering microscopic images
With the results of this research, we can better determine which patients actually benefit from intensive follow-up or additional treatments to ultimately improve the survival of people with squamous cell carcinoma.
More detailed information
Dr. Marlies Wakkee
Role Erasmus MC: